Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Tomoko Nii"'
Autor:
Tadao Akizawa, Kazuhiro Shiizaki, Qunsheng Yuan, Ikuji Hatamura, Fumie Saji, Tomoko Nii-Kono, Takashi Shigematsu, Masafumi Fukagawa
Publikováno v:
American Journal of Nephrology. 28:59-66
Aims: In this study, we investigated the effects of direct injection (DI) of calcitriol or maxacalcitol into the hyperplastic parathyroid gland (PTG) on altered gene expression related to the advanced status of secondary hyperparathyroidism (SHPT). M
Autor:
Tomoko Nii
Publikováno v:
Oleoscience. 6:363-370
Autor:
Hideyuki Yamato, Kiyoshi Kurokawa, Masafumi Fukagawa, Tomoko Nii-Kono, Yoshiko Iwasaki-Ishizuka
Publikováno v:
Nephrology Dialysis Transplantation. 20:1904-1911
Background. Adynamic bone disease (ABD), which is characterized by reduced bone formation and resorption, has become an increasingly common manifestation of bone abnormalities in patients with end-stage renal failure. It has been recognized that skel
Autor:
Fumiyoshi Ishii, Tomoko Nii
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 41:257-262
The characteristics of mixed phospholipids were examined when used as dispersing agents and emulsifiers. Synthesized phospholipids were mixed to investigate the potential effects of different hydrophilic or lipophilic groups on emulsification and dis
Autor:
Fumiyoshi Ishii, Tomoko Nii
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 39:57-63
We investigated characteristics of various phosphatidylcholines (PCs) used as dispersing agents and emulsifiers. Six PCs with different lengths of acyl hydrocarbon chains and different degrees of unsaturated acyl hydrocarbon chains were selected to e
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 27:323-332
We examined hydrogenated purified egg yolk lecithins, having practical advantages over non-hydrogenated ones, as liposomal membrane materials. Liposomes were prepared by the microencapsulation vesicle (MCV) method in which liposomes are formed throug
Autor:
Tomioka Kenichi, Takeshi Shigenaga, Nami Hisamichi, Tomoko Nii, Ken-ichi Suzuki, Tomihisa Kawasaki, Isao Yanagisawa, Osamu Inagaki, Seiji Kaku, Yuzo Matsumoto, Kazuo Sato, Masato Ichihara, Yumiko Moritani, Seijiro Akamatsu
Publikováno v:
European Journal of Pharmacology. 439:43-52
The pharmacological properties of YM-57029 ({4-[4-(4-carbamimidoylphenyl)-3-oxopiperazin-1-yl]piperidino}acetic acid monohydrochloride trihydrate), a novel glycoprotein IIb/IIIa antagonist were examined in this study. YM-57029 inhibited fibrinogen bi
Autor:
Tomihisa Kawasaki, Kazuo Sato, Yumiko Moritani, Seiji Kaku, Hiroshi Arai, Ken-ichi Suzuki, Yuta Taniuchi, Yuzo Matsumoto, Isao Yanagisawa, Takeshi Shigenaga, Seijiro Akamatsu, Masato Ichihara, Tomoko Nii, Nami Hisamichi, Hiroshi Matsushima, Osamu Inagaki, Tomioka Kenichi
Publikováno v:
Drug Development Research. 55:149-161
We examined the biochemical properties of YM-57029 ({4-[4-(4-Carbamimidoylphenyl)-3-oxopiperazin-1-yl]piperidino}acetic acid monohydrochloride trihydrate) and the pharmacodynamics and pharmacokinetics of its prodrug, YM128 (Ethyl (Z)-(4-{4-[4-(N 2 -h
Autor:
Fumiyoshi Ishii, Tomoko Nii
The properties of phospholipids as emulsifiers, stabilisers, or dispersing agents in micro- or nanoparticulate drug carriers were reviewed. Three types of purified egg yolk lecithins (PELs) with different iodine values (IV), (i.e., PEL [IV = 76], R-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef9f83584b451de288e909c4f0e4a2bc
https://doi.org/10.1016/b978-0-444-62614-1.00022-3
https://doi.org/10.1016/b978-0-444-62614-1.00022-3
Autor:
Akimitsu Miyauchi, Hironori Yamamoto, Kanshi Minamitani, Hiroko Segawa, Yoshiko Tani, Toshiyuki Yasuda, Ken-ichi Miyamoto, Ichiro Ohkido, Hiroo Niimi, Masanori Minagawa, Kyoko Morita, Eiji Takeda, Yutaka Taketani, Tomoko Nii
Publikováno v:
Clinical and Experimental Nephrology. 5:144-152
Background. X-linked hypophosphatemia (XLH) is the most common form of familial hypophosphatemic rickets, which results from impaired renal phosphate (Pi) reabsorption, renal vitamin D metabolism, and skeletal mineralization. PHEX the gene responsibl